8-K - Amylyx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On September 9, 2025, Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) entered into an underwriting agreem

Material Agreement

$10.00$164.0M$188.7M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated September 9, 2025 5.1 Opinion of Goodwin Procter LLP

Exhibits Only

Exhibits (3)

1.1

EX-1.1

5.1

EX-5.1

8-K